Inactive Instrument

CM LIFE28 Nasdaq

CMIIU

US1258422039

This article is reserved for members

Already a member?

Not a member ?

Free registration

Latest news about CM LIFE28

Standard BioTools Inc.(NasdaqGM:SLGC) dropped from S&P Global BMI Index	Jan. 10	CI
Standard BioTools Inc.(NasdaqGM:SLGC) dropped from S&P TMI Index	Jan. 10	CI
Somalogic, Inc. Provides Revenue Guidance for Fourth Quarter and Full Year 2023	Jan. 08	CI
Declaration of Voting Results by SomaLogic Inc	Jan. 05	CI
Declaration of Voting Results by SomaLogic Inc	Jan. 05	CI
Declaration of Voting Results by SomaLogic Inc	Jan. 05	CI
Declaration of Voting Results by SomaLogic Inc	Jan. 05	CI
Declaration of Voting Results by SomaLogic Inc	Jan. 05	CI
Standard BioTools Says Merger With SomaLogic Completed	Jan. 05	MT
SomaLogic, Standard BioTools Receive Shareholder Approvals for Pending Merger	Jan. 05	MT
SomaLogic, Inc.(NasdaqGM:SLGC) dropped from NASDAQ Composite Index	Jan. 05	CI
Madryn Asset Addresses SomaLogic?s Failure to Obtain Requisite Shareholder Support for the Proposed Merger with Standard BioTools	Jan. 04	CI
Madryn Asset Management, LP Sends an Email to Stockholders in Connection with Somalogic, Inc.?s Special Meeting of Stockholders	Jan. 04	CI
Madryn Asset Management Sent a Letter to the Delaware Court of Chancery	Jan. 03	CI
Madryn Asset Provides Information to the Shareholders	Jan. 03	CI
Egan-Jones Recommends SomaLogic Shareholders Vote Against Proposed Merger with Standard BioTools	Jan. 03	CI
Jason Ryan Issues a Letter to Shareholders of SomaLogic Inc	Jan. 03	CI
Jason Ryan Issues a Letter to Shareholders of SomaLogic Inc	Jan. 03	CI
Jason Ryan Issues a Letter to Shareholders of SomaLogic Inc	Jan. 03	CI
Jason Ryan Issues a Letter to Shareholders of SomaLogic Inc	Jan. 03	CI
Jason Ryan Issues a Letter to Shareholders of SomaLogic Inc	Jan. 03	CI
SomaLogic Sends an Open Letter to Shareholders	Jan. 02	CI
SomaLogic Sends an Open Letter to Shareholders	Jan. 02	CI
SomaLogic Sends an Open Letter to Shareholders	Jan. 02	CI
SomaLogic Sends an Open Letter to Shareholders	Jan. 02	CI

CM Life Sciences II Inc. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company is engaged in pursuing an initial business combination target in any industry, sector or geographic region. It intends to focus on the life sciences sector. The Company neither engages in any business operations nor generates any revenues.

Sector

Calendar

2024-05-08 - Q1 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company